GlycoMimetics Inc (GLYC) — Cash Flow-to-Debt Ratio
GlycoMimetics Inc (GLYC) has a Cash Flow-to-Debt Ratio of -1.95x as of March 2025, meaning its operating cash flow of $-5.11 Billion could theoretically repay -2% of its total liabilities ($2.62 Billion) in one year. Check GLYC total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GlycoMimetics Inc Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for GlycoMimetics Inc across 14 annual periods. Also explore GLYC total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for GlycoMimetics Inc (2011–2024)
Year-by-year debt coverage analysis for GlycoMimetics Inc. For market capitalisation and broader financial context, see GLYC market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.38x | $-31.10 Million | $5.78 Million | ▼ -6.5% |
| 2023 | -5.05x | $-34.88 Million | $6.90 Million | ▲ +3.4% |
| 2022 | -5.23x | $-46.46 Million | $8.88 Million | ▼ -16.0% |
| 2021 | -4.51x | $-57.49 Million | $12.74 Million | ▼ -68.0% |
| 2020 | -2.69x | $-39.24 Million | $14.61 Million | ▲ +28.9% |
| 2019 | -3.78x | $-51.98 Million | $13.77 Million | ▲ +18.3% |
| 2018 | -4.62x | $-43.33 Million | $9.38 Million | ▼ -37.9% |
| 2017 | -3.35x | $-29.77 Million | $8.88 Million | ▲ +20.1% |
| 2016 | -4.20x | $-29.73 Million | $7.09 Million | ▼ -306.7% |
| 2015 | -1.03x | $-8.24 Million | $7.99 Million | ▼ -55.6% |
| 2014 | -0.66x | $-4.28 Million | $6.46 Million | ▲ +89.9% |
| 2013 | -6.54x | $-15.54 Million | $2.38 Million | ▼ -267.9% |
| 2012 | -1.78x | $-10.47 Million | $5.89 Million | ▼ -362.5% |
| 2011 | 0.68x | $13.85 Million | $20.45 Million | — |